Table 5.
Parameters | Placebo | MO Lozenge | MO + CC Lozenge | p-Value |
---|---|---|---|---|
(n = 22) | (n = 22) | (n = 24) | ||
Oral Inflammation | ||||
Baseline | 0.14 ± 0.35 | 0.27± 0.55 | 0.21 ± 0.25 | ns |
Week 4 | 0.05 ± 0.21 | 0.05 ± 0.22 | 0.09 ± 0.42 | ns |
p-Value | ns | ns | ns | |
% Decrease | 64.28 | 81.48 | 57.14 | <0.001 |
Gingival Index | ||||
Baseline | 1.77 ± 0.69 | 2.18 ± 1.59 | 1.88 ± 0.61 | ns |
Week 4 | 1.55 ± 0.51 | 1.62 ± 0.59 | 1.48 ± 0.51 | ns |
p-Value | ns | ns | <0.05 | |
% Decrease | 12.43 | 25.69 | 21.28 | <0.001 |